Results 71 to 80 of about 7,739 (166)
Clinical utility of ivabradine in cardiovascular disease management: current status
, 2014 Giuseppe MC Rosano,1,2 Cristiana Vitale,1,2 Ilaria Spoletini,1 Maurizio Volterrani11Department of Medical Sciences, IRCCS San Raffaele Pisana, Rome, Italy; 2Cardiovascular and Cell Sciences Research Institute, St George's University of London, London,
Volterrani M +3 more
core
Anti-ischaemic effect of ivabradine
, 2006 Ivabradine, the first representative of a new class of exclusive heart rate-reducing agents, selectively inhibits the I(f) current in the sinoatrial node.
CECONI, Claudio +2 more
core +1 more source
Cardiovascular Health in Women—Across the Lifespan
Clinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar +5 more
wiley +1 more source
Advances in the management of heart failure: the role of ivabradine
, 2016 Ursula Müller-Werdan,1,2 Georg Stöckl,3 Karl Werdan4 1Charité – Universitätsmedizin Berlin, 2Protestant Geriatric Centre, Berlin, 3Department of Medical Affairs, Servier Deutschland GmbH, Munich, 4Department of Medicine ...
Müller-Werdan U, Stöckl G, Werdan K
core
Ivabradine in patients with heart failure: a systematic literature review
, 2023 Background: Heart failure is a chronic disease linked with significant morbidity and mortality, and uncontrolled resting heart rate is a risk factor for adverse outcomes. This systematic literature review aimed to assess the efficacy, safety, and patient-
Zeba M. Khan +4 more
core +1 more source
The Scientific World Journal, 2012 Ivabradine is a novel heart rate lowering agent that inhibits If ionic current in the sinus node and demonstrates antiischaemic and antianginal activity.
Jacek Owczarek +2 more
doaj +1 more source
Selective HCN1 channels inhibition by ivabradine in mouse rod photoreceptors
, 2008 Purpose: To evaluate in mammalian rod photoreceptors the selectivity for hyperpolarization-activated cyclic nucleotide-gated (Hcn1, coded by Hcn1) over potassium-selective (Kir 2.4, coded by Kcnj14) channels of ivabradine, a selective inhibitor of the ...
CERVETTO, LUIGI +3 more
core +1 more source
Ivabradine block of If is current dependent
, 2002 Ivabradine block of If is current ...
M. Baruscotti, D. DiFrancesco, A. Bucchi
core +2 more sources
Quality of life with ivabradine in patients with angina pectoris [PDF]
, 2016 Background—To explore the effect of ivabradine on angina-related quality of life (QoL) in patients participating in the Study Assessing the Morbidity–Mortality Benefits of the If Inhibitor Ivabradine in Patients with Coronary Artery Disease (SIGNIFY) QoL
Steg, Philippe Gabriel +7 more
core +1 more source